期刊文献+

卵巢癌患者血液高凝状态临床研究进展 被引量:15

Clinical advancement of hypercoagulability in patients with ovarian cancer
下载PDF
导出
摘要 卵巢癌患者的静脉血栓发生率远高于其他妇科肿瘤,约20%以上的卵巢癌患者存在高凝状态。肿瘤可导致血液高凝状态,而凝血功能的过度激活也极大地促进肿瘤的进展,是影响患者预后的重要因素。近年来,高凝状态逐渐成为卵巢癌研究领域的新热点,本文将对卵巢癌患者高凝状态的形成机制、临床意义及相关治疗进展进行综述。 The incidence of venous thromboembolism in patients with ovarian cancer is much higher than other gynecologic cancers. Approximate 20%of ovarian cancer patients have hypercoagulable status during different phases of their disease. Ovarian cancer itself can induce hypercoagulability, but meanwhile the over activated coagulation system may promote disease progression. Coagulation system disorder is one of the most important prognostic factors in ovarian cancer. Recently, hypercoagulability becomes a hot spot in the ovarian cancer research ifeld. This article reviews the mechanism of hypercoagulability, its clinical implication and correlated treatment in ovarian cancer patients.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2015年第3期231-234,共4页 China Oncology
基金 上海市科学技术委员会重点项目(12411950300)
关键词 卵巢癌 高凝状态 白细胞介素-6 Ovarian cancer Hypercoagulability Interleukin-6
  • 相关文献

参考文献28

  • 1WANG X, WANG E, KAVANAGHJ J, et al. Ovarian cancer, the coagulation pathway, and inflammation[J] .J Transl Med,2005,3:25-25. 被引量:1
  • 2LABELLE M, BEGUM S, HYNES R O. Direct signaling between platelets and cancer cells induces an epithelialmesenchymal-like transition and promotes metastasis[J] . Cancer Cell, 2011, 20(5): 576-590. 被引量:1
  • 3GA Y LJ, FELDING-HABERMANN B. Contribution of platelets to tumour metastasis[J] . Nat Rev Cancer, 2011, 11(2): 123-134. 被引量:1
  • 4RODRIGUEZ A 0, WUN T, CHEW H, et al. Venous thromboembolism in ovarian cancer[J] . Gynecol Oncol, 2007,105(3): 784-790. 被引量:1
  • 5PEEDICA YIL A, WEAVER A, LI X, et al. Incidence and timing of venous thromboembolism after surgery for gynecological cancer[J] . Gynecol Oncol, 2011, 121(1): 64- 69. 被引量:1
  • 6ALLENSWORTH S K, LANGSTRAAT C L, MartinJ R, et al. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer[J] . Gynecol Oncol, 2013,130(3): 499-504. 被引量:1
  • 7STONE R L, NICK A M, MCNEISH I A, et al. Paraneoplastic thrombocytosis in ovarian cancer[J] . N EnglJ Med, 2012, 366(7): 610-618. 被引量:1
  • 8TAS F, KILIC L, BILGIN E, et al. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer[J] . IntJ Gynecol Cancer, 2013, 23(2): 276- 28l. 被引量:1
  • 9MA X, WANG Y, SHENG H, et al. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer[J] .J Obstet Gynaecol Res, 2014, 40(1): 178-183. 被引量:1
  • 10COHENJ G, ARTHUR-QUAN T, RIMEL BJ, et al. Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival[J] . Gynecol Oncol, 2014, 132(3): 556-559. 被引量:1

同被引文献155

引证文献15

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部